Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.

Ribi, Karin; Luo, Weixiu; Colleoni, Marco; Karlsson, Per; Chirgwin, Jacquie; Aebi, Stefan; Jerusalem, Guy; Neven, Patrick; Di Lauro, Vincenzo; Gomez, Henry L; Ruhstaller, Thomas; Abdi, Ehtesham; Biganzoli, Laura; Müller, Bettina; Barbeaux, Annelore; Graas, Marie-Pascale; Rabaglio, Manuela; Francis, Prudence A; Foukakis, Theodoros; Pagani, Olivia; ... (2020). Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial. British journal of cancer, 122(7), p. 1119. Nature Publishing Group 10.1038/s41416-019-0709-x

[img] Text
s41416-019-0709-x.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (182kB) | Request a copy

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Bernhard, Jürg

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0007-0920

Publisher:

Nature Publishing Group

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

26 May 2020 17:07

Last Modified:

26 May 2020 17:07

Publisher DOI:

10.1038/s41416-019-0709-x

PubMed ID:

31949268

BORIS DOI:

10.7892/boris.143130

URI:

https://boris.unibe.ch/id/eprint/143130

Actions (login required)

Edit item Edit item
Provide Feedback